{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:52:20Z","timestamp":1793436740008,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["2011-5249"],"award-info":[{"award-number":["2011-5249"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s10815-017-1014-3","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T02:47:37Z","timestamp":1503370057000},"page":"1475-1482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF\/PGD"],"prefix":"10.1007","volume":"34","author":[{"given":"I. A. P.","family":"Derks-Smeets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. C.","family":"van Tilborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"van Montfoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. L.","family":"Torrance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Meijer-Hoogeveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Broekmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C. F. M.","family":"Dreesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. D. C.","family":"Paulussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. C. G.","family":"Tjan-Heijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Homminga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M. J.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G. E. M.","family":"Ausems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"de Rycke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E. M.","family":"de Die-Smulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Verpoest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"van Golde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"key":"1014_CR1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329\u201333.","journal-title":"J Clin Oncol"},{"key":"1014_CR2","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","volume":"95","author":"K Yoshida","year":"2004","unstructured":"Yoshida K, Miki Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 2004;95:866\u201371.","journal-title":"Cancer Sci"},{"key":"1014_CR3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/carcin\/bgq069","volume":"31","author":"PJ O\u2019Donovan","year":"2010","unstructured":"O\u2019Donovan PJ, Livingston DM. BRCA1 and BRCA2: breast\/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair. Carcinogenesis. 2010;31:961\u20137.","journal-title":"Carcinogenesis"},{"key":"1014_CR4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev.pathol.3.121806.151422","volume":"4","author":"AR Venkitaraman","year":"2009","unstructured":"Venkitaraman AR. Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu Rev Pathol. 2009;4:461\u201387.","journal-title":"Annu Rev Pathol"},{"key":"1014_CR5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","volume":"28","author":"K Oktay","year":"2010","unstructured":"Oktay K, Kim JY, Barad D, Babayev SN. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks. J Clin Oncol. 2010;28:240\u20134.","journal-title":"J Clin Oncol"},{"key":"1014_CR6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.fertnstert.2015.07.1162","volume":"104","author":"M Shapira","year":"2015","unstructured":"Shapira M, Raanani H, Feldman B, Srebnik N, Dereck-Haim S, Manela D, et al. BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles. Fertil Steril. 2015;104:1162\u20137.","journal-title":"Fertil Steril"},{"key":"1014_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-006-9220-1","volume":"100","author":"I Rzepka-G\u00f3rska","year":"2006","unstructured":"Rzepka-G\u00f3rska I, Tarnowski B, Chudecka-Glaz A, G\u00f3rski B, Ziel\u00ednska D, Toloczko-Grabarek A. Premature menopause in patients with BRCA1 gene mutation. Breast Cancer Res Treat. 2006;100:59\u201363.","journal-title":"Breast Cancer Res Treat"},{"key":"1014_CR8","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.fertnstert.2013.01.109","volume":"99","author":"A Finch","year":"2013","unstructured":"Finch A, Valentini A, Greenblatt E, Lynch HT, Ghadirian P, Armel S, et al. Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation. Fertil Steril. 2013;99:1724\u20138.","journal-title":"Fertil Steril"},{"key":"1014_CR9","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/cncr.27952","volume":"199","author":"WT Lin","year":"2013","unstructured":"Lin WT, Beattie M, Chen LM, Oktay K, Crawford SL, Gold EB, et al. Comparison of age at natural menopause in BRCA1\/2 mutation carriers with a non-clinic-based sample of women in northern California. Cancer. 2013;199:1652\u20139.","journal-title":"Cancer"},{"key":"1014_CR10","doi-asserted-by":"crossref","first-page":"172ra21","DOI":"10.1126\/scitranslmed.3004925","volume":"5","author":"S Titus","year":"2013","unstructured":"Titus S, Li F, Stobezki R, Akula K, Unsal E, Jeong K, et al. Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Sci Transl Med. 2013;5:172ra21.","journal-title":"Sci Transl Med"},{"key":"1014_CR11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/IGC.0000000000000058","volume":"24","author":"R Michaelson-Cohen","year":"2014","unstructured":"Michaelson-Cohen R, Mor P, Srebnik N, Beller U, Levy-Lahad E, Elder-Geva T. BRCA mutation carriers do not have compromised ovarian reserve. Int J Gynecol Cancer. 2014;24:233\u20137.","journal-title":"Int J Gynecol Cancer"},{"key":"1014_CR12","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.fertnstert.2014.08.014","volume":"102","author":"ET Wang","year":"2014","unstructured":"Wang ET, Pisarska MD, Bresee C, Chen YD, Lester J, Afshar Y, et al. BRCA1 germline mutations may be associated with reduced ovarian reserve. Fertil Steril. 2014;102:1723\u20138.","journal-title":"Fertil Steril"},{"key":"1014_CR13","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/humrep\/dew044","volume":"31","author":"KA Phillips","year":"2016","unstructured":"Phillips KA, Collins IM, Milne RL, McLachlan SA, Friedlander M, Hickey M, et al. Anti-m\u00fcllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations. Hum Reprod. 2016;31:1126\u201332.","journal-title":"Hum Reprod"},{"key":"1014_CR14","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/bcr1387","volume":"8","author":"E Friedman","year":"2006","unstructured":"Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P, Neuhausen SL, et al. Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Res. 2006;8:R15.","journal-title":"Breast Cancer Res"},{"key":"1014_CR15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ajhb.20978","volume":"22","author":"R Moslehi","year":"2010","unstructured":"Moslehi R, Singh R, Lessner L, Friedman JM. Impact of BRCA mutations on female fertility and offspring sex ratio. Am J Hum Biol. 2010;22:201\u20135.","journal-title":"Am J Hum Biol"},{"key":"1014_CR16","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.fertnstert.2008.12.052","volume":"93","author":"T Pal","year":"2010","unstructured":"Pal T, Keefe D, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group. Fertility in women with BRCA mutations: a case-control study. Fertil Steril. 2010;93:1805\u20138.","journal-title":"Fertil Steril"},{"key":"1014_CR17","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1098\/rspb.2011.1697","volume":"279","author":"KR Smith","year":"2012","unstructured":"Smith KR, Hanson HA, Mineau GP, Buys SS. Effects of BRCA1 and BRCA2 mutations on female fertility. Proc Biol Sci. 2012;279:1389\u201395.","journal-title":"Proc Biol Sci"},{"key":"1014_CR18","doi-asserted-by":"crossref","first-page":"e0127363","DOI":"10.1371\/journal.pone.0127363","volume":"10","author":"F Kwiatkowski","year":"2015","unstructured":"Kwiatkowski F, Arbre M, Bidet Y, Laquet C, Uhrhammer N, Bignon YJ. BRCA mutations increase fertility in families at hereditary breast\/ovarian cancer risk. PLoS One. 2015;10:e0127363.","journal-title":"PLoS One"},{"key":"1014_CR19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","volume":"91","author":"SL Broer","year":"2009","unstructured":"Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91:705\u201314.","journal-title":"Fertil Steril"},{"key":"1014_CR20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/pd.1708","volume":"27","author":"C Spits","year":"2007","unstructured":"Spits C, De Rycke M, Van Ranst N, Verpoest W, Lissens W, Van Steirteghem A, et al. Preimplantation genetic diagnosis for cancer predisposition syndromes. Prenat Diagn. 2007;27:447\u201356.","journal-title":"Prenat Diagn"},{"key":"1014_CR21","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/humrep\/dev122","volume":"30","author":"M Rycke De","year":"2015","unstructured":"De Rycke M, Belva F, Goossens V, Moutou C, SenGupta SB, Traeger-Synodinos J, et al. ESHRE PGD consortium data collection XIII: cycles from January to December 2010 with pregnancy follow-up to October 2011. Hum Reprod. 2015;30:1763\u201389.","journal-title":"Hum Reprod"},{"key":"1014_CR22","doi-asserted-by":"crossref","unstructured":"Gail MH. Frequency matching. Encyclopedia of Biostatistics. 3. 2005.","DOI":"10.1002\/0470011815.b2a03067"},{"key":"1014_CR23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/humupd\/dmq041","volume":"17","author":"MD Sterrenburg","year":"2011","unstructured":"Sterrenburg MD, Veltman-Verhulst SM, Eijkemans MJ, Hughes EG, Macklon NS, Broekmans FJ, et al. Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis. Hum Reprod Update. 2011;17:184\u201396.","journal-title":"Hum Reprod Update"},{"key":"1014_CR24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41\u20137.","journal-title":"Hum Reprod"},{"key":"1014_CR25","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ejhg.2013.50","volume":"21","author":"M Dr\u00fcsedau","year":"2013","unstructured":"Dr\u00fcsedau M, Dreesen JC, Derks-Smeets I, Coonen E, van Golde R, van Echten-Arends J, et al. PGD for hereditary breast and ovarian cancer: the route to universal tests for BRCA1 and BRCA2 mutation carriers. Eur J Hum Genet. 2013;21:1361\u20138.","journal-title":"Eur J Hum Genet"},{"key":"1014_CR26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10549-014-2951-5","volume":"145","author":"IA Derks-Smeets","year":"2014","unstructured":"Derks-Smeets IA, de Die-Smulders CE, Mackens S, van Golde R, Paulussen AD, Dreesen J, et al. Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors. Breast Cancer Res Treat. 2014;145:673\u201381.","journal-title":"Breast Cancer Res Treat"},{"key":"1014_CR27","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.fertnstert.2012.01.093","volume":"97","author":"J Domingo","year":"2012","unstructured":"Domingo J, Guill\u00e9n V, Ayll\u00f3n Y, Mart\u00ednez M, Mu\u00f1oz E, Pellicer A, et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril. 2012;97:930\u20134.","journal-title":"Fertil Steril"},{"key":"1014_CR28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10815-015-0428-z","volume":"32","author":"ER Cardozo","year":"2015","unstructured":"Cardozo ER, Thomson AP, Karmon AE, Dickinson KA, Wright DL, Sabatini ME. Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience. J Assist Reprod Genet. 2015;32:587\u201396.","journal-title":"J Assist Reprod Genet"},{"key":"1014_CR29","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","volume":"14","author":"J Bines","year":"1996","unstructured":"Bines J, Oleske D, Cobleigh M. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14:1718\u201329.","journal-title":"J Clin Oncol"},{"key":"1014_CR30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/GME.0000000000000633","volume":"23","author":"TC Tilborg Van","year":"2016","unstructured":"Van Tilborg TC, Broekmans FJ, Pijpe A, Schrijver LH, Mooij TM, Oosterwijk JC, et al. Do BRCA1\/2 mutation carriers have an earlier onset of natural menopause? Menopause. 2016;23:903\u201310.","journal-title":"Menopause"},{"key":"1014_CR31","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1200\/JCO.2013.49.3007","volume":"31","author":"IM Collins","year":"2013","unstructured":"Collins IM, Milne RL, McLachlan SA, Friedlander M, Hickey M, Weideman PC, et al. Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for research into familial breast cancer. J Clin Oncol. 2013;31:3920\u20135.","journal-title":"J Clin Oncol"},{"key":"1014_CR32","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1093\/humrep\/dew242","volume":"31","author":"TC Tilborg Van","year":"2016","unstructured":"Van Tilborg TC, Derks-Smeets IA, Bos AM, Oosterwijk JC, Van Golde RJ, De Die-Smulders CE, et al. Serum AMH levels in healthy women from BRCA1\/2 mutated families: are they reduced? Hum Reprod. 2016;31:2651\u20139.","journal-title":"Hum Reprod"},{"key":"1014_CR33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jmedgenet-2013-101974","volume":"51","author":"RM Brohet","year":"2014","unstructured":"Brohet RM, Velthuizen ME, Hogervorst FB, Meijers-Heijboer HE, Seynaeve C, Coll\u00e9e MJ, et al. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. J Med Genet. 2014;51:98\u2013107.","journal-title":"J Med Genet"},{"key":"1014_CR34","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000167820","volume":"122","author":"E Cabuy","year":"2008","unstructured":"Cabuy E, Newton C, Slijepcevic P. BRCA1 knock-down causes telomere dysfunction in mammary epithelial cells. Cytogenet Genome Res. 2008;122:336\u201342.","journal-title":"Cytogenet Genome Res"},{"key":"1014_CR35","doi-asserted-by":"crossref","unstructured":"Marioni RE, Harris SE, Shah S, McRae AF, von Zglinicki T, Martin-Ruiz C, et al. The epigenetic clock and telomere length are independently associated with chronological age and mortality. Int J Epidemiol 2016.","DOI":"10.1093\/ije\/dyw041"},{"key":"1014_CR36","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1095\/biolreprod.108.069641","volume":"79","author":"B Xiong","year":"2008","unstructured":"Xiong B, Li S, Ai JS, Yin S, Ouyang YC, Sun SC, et al. BRCA1 is required for meiotic spindle assembly and spindle assembly checkpoint activation in mouse oocytes. Biol Reprod. 2008;79:718\u201326.","journal-title":"Biol Reprod"},{"key":"1014_CR37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1242\/dev.00888","volume":"131","author":"SK Sharan","year":"2004","unstructured":"Sharan SK, Pyle A, Coppola V, Babus J, Swaminathan S, Benedict J, et al. BRCA2 deficiency in mice leads to meiotic impairment and infertility. Development. 2004;131:131\u201342.","journal-title":"Development"},{"key":"1014_CR38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","volume":"108","author":"AR Venkitaraman","year":"2002","unstructured":"Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 2002;108:171\u201382.","journal-title":"Cell"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-017-1014-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-017-1014-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-017-1014-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T07:58:44Z","timestamp":1719388724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-017-1014-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["1014"],"URL":"https:\/\/doi.org\/10.1007\/s10815-017-1014-3","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]}}}